Activity of two phase I drugs N-methylformamide (NSC-3051) and Echinomycin (NSC-526417) against fresh surgical explants of human tumors in the 6-day subrenal capsule (SRC) assay William R. CobbArthur E. BogdenDoreen J. LePage Preclinical Pages: 5 - 9
Survival and cell cycle kinetics responses of Chinese hamster ovary cells, and clones of human adenocarcinoma of the stomach and astrocytoma to diaziquone (AZQ) in vitro S. C. BarrancoG. A. SchechterN. H. Rubin Preclinical Pages: 11 - 20
Comparative in vitro antitumor activity of homoharringtonine and harringtonine against clonogenic human tumor cells T. L. JiangR. H. LiuS. E. Salmon Preclinical Pages: 21 - 25
Application of a microsomal drug activation system in a human tumor cloning assay Hans-Robert MetelmannDaniel D. Von Hoff Preclinical Pages: 27 - 32
The human tumor cloning assay in cancer drug development Peter AgreThomas E. Williams Preclinical Pages: 33 - 45
Pharmacokinetics of 5,6-dihydro-5-azacytidine (NSC-264880) in the foxhound Louis MalspeisHaiyung ChengAlfred E. Staubus Preclinical Pages: 47 - 58
Pharmacokinetics of 4′-epi-doxorubicin in man H. WeenenJ. LankelmaH. M. Pinedo Clinical Pages: 59 - 64
Mitoxantrone hydrochloride (NSC-310739) in lymphoma Charles A. Coltman Jr.Terri M. McDanielDaniel D. Von Hoff Clinical Pages: 65 - 70
Anaphylactoid reactions associated with bisantrene infusions J. William MyersDaniel D. Von HoffRobert Pocelinko Clinical Pages: 85 - 88
Phase II evaluation of MGBG in non-small cell carcinoma of the lung Ralph B. VanceWilliam A. Knight IIIAlbert F. LoBuglio Clinical Pages: 89 - 93
